HPM Partners »

Neumora Therapeutics shares owned by HPM Partners

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by HPM Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.2M 243k 13.21

More positions owned by HPM Partners

Vanguard Index Fds Etf (VOO)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Spdr S&p 500 Etf Tr Etf (SPY)
Procter And Gamble Stock (PG)
NVIDIA Corporation (NVDA)
Ishares Tr Etf (IVV)
Vanguard Tax-managed Fds Stock (VEA)
Ishares Tr Etf (IEFA)
Amazon Stock (AMZN)
Eli Lilly & Co Stock (LLY)
Ishares Tr Stock (AGG)
Ishares Tr Stock (QUAL)
Alphabet Stock (GOOGL)
Facebook Inc cl a (META)

View all positions for HPM Partners

Top funds holding Neumora Therapeutics

Softbank Group Corp
BlackRock
T. Rowe Price Investment Management
BlackRock
MIC Capital Management UK
ICONIQ Capital
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Vanguard Group
Siren
EcoR1 Capital
Geode Capital Management
Johnson & Johnson
Avidity Partners Management
OrbiMed Advisors
State Street Corporation

View all funds holding Neumora Therapeutics